CurvaFix Gains $39m for US Pelvic Fracture Therapy Launch

CurvaFix has recently revealed their new Chief Executive Officer, Mark Foster, as they mark the end of a period of raising finance through the sale of shares equivalent to $39 million.

The US Medical Device firm manufactured equipment used in treating cracks and splintering in curved bones. Mark Foster will be taking over the position of Chief Executive Officer from CurvaFix’s founder, Steve Dimmer.

After a change in management, Dimmer plans to move into a strategic adviser position.

A number of the company’s current investors including Sectoral Asset Management joined MVM Partners as they spearheaded the funding round.

CurvaFix intends to utilise the money to increase access to their pelvic fragility fracture therapy, introducing the new CurvaFix IM implant throughout the United States.

MVM partner and lead of the finance round, Eric Fritz, explained how “CurvaFix’s ability to benefit patients, physicians, and health systems, while simultaneously addressing the undertreated FFP segment makes CurvaFix a rare asset in the crowded world of orthopaedics.”

© Copyright 2010-2021 Zenopa LTD. All Rights Reserved.